Related Articles
Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients
Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
Estrogen receptor α and β, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast
Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray